Cardiovascular impact of testosterone therapy for hypogonadism
Hypogonadism
Related content
Erectile and Sexual Functions and DysfunctionsUro-Oncology
Late-onset Hypogonadism and Testosterone Therapy - A Summary of Guidelines from the American Urological Association and the European Association of Urology
Eur Urol Focus.
Fode M, Salonia A, Minhas S, Burnett AL, Shindel AW
doi: 10.1016/j.euf.2019.02.021.
COMMENTED
Hypogonadism
Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
JAMA Intern Med.
Walker RF, Zakai NA, MacLehose RF, Cowan LT, Adam TJ, Alonso A, Lutsey PL
doi: 10.1001/jamainternmed.2019.5135.
Hypogonadism
Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy
J Sex Med.
Lundy SD, Parekh NV, Shoskes DA
doi: 10.1016/j.jsxm.2020.03.006.
Reproductive Health
Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male
Eur Urol Focus.
Scovell JM, Khera M
doi: 10.1016/j.euf.2018.07.033.
HypogonadismReproductive Health
Novel Therapy for Male Hypogonadism
Curr Urol Rep.
Carrasquillo R, Chu K,
Ramasamy R
doi: 10.1007/s11934-018-0816-x.
Hypogonadism
Relationship between testosterone in serum, saliva and urine during treatment with intramuscular testosterone undecanoate in gender dysphoria and male hypogonadism
Andrology.
Lood Y, Aardal-Eriksson E, Webe C, Ahlner J, Ekman B, Wahlberg J
doi: 10.1111/
Erectile and Sexual Functions and Dysfunctions
Testosterone Replacement Therapy for Sexual Symptoms
Sex Med Rev.
Rastrelli G, Guaraldi F, Reismann Y, Sforza A, Isidori AM, Maggi M,
Corona G
doi: 10.1016/j.sxmr.2018.11.005.
Hypogonadism
Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies
Acta Clin Belg.
Bastin J, Werbrouck E, Verbiest A, Punie K, Bechter O, Woei-A-Jin SF, Wolter P, Wildiers H, Lerut E, Dumez H, Decallonne B, Clement P, Vanderschueren D, Albersen M, Oyen R, Schöffski P, Beuselinck B
doi: 10.1080/17843286.2018.
Testosteron-Therapie ‒ eine effektive Option zur Behandlung des Hypogonadismus*
Diese Veröffentlichung wurde durch die finanzielle Unterstützung von Bayer (Schweiz) AG ermöglicht.